Stati Uniti - Ingliż - NLM (National Library of Medicine)

elanco us inc. - tulathromycin (unii: q839i13422) (tulathromycin - unii:q839i13422) - swine increxxa 25 injectable solution is indicated for the treatment of swine respiratory disease (srd) associated with actinobacillus pleuropneumoniae, pasteurella multocida, bordetella bronchiseptica, haemophilus parasuis, and mycoplasma hyopneumoniae ; and for the control of srd associated with actinobacillus pleuropneumoniae, pasteurella multocida, and mycoplasma hyopneumoniae in groups of pigs where srd has been diagnosed. suckling calves, dairy calves, and veal calves brd - increxxa 25 injectable solution is indicated for the treatment of bovine respiratory disease (brd) associated with mannheimia haemolytica, pasteurella multocida, histophilus somni, and mycoplasma bovis . the use of increxxa 25 injectable solution is contraindicated in animals previously found to be hypersensitive to the drug.

Stati Uniti - Ingliż - NLM (National Library of Medicine)

elanco us inc. - imidacloprid (unii: 3bn7m937v8) (imidacloprid - unii:3bn7m937v8), moxidectin (unii: ngu5h31yo9) (moxidectin - unii:ngu5h31yo9) - advantage multi for cats is indicated for the prevention of heartworm disease caused by dirofilaria immitis. advantage multi for cats kills adult fleas (ctenocephalides felis ) and is indicated for the treatment of flea infestations. advantage multi for cats is also indicated for the treatment and control of ear mite (otodectes cynotis ) infestations and the following intestinal parasites: intestinal parasite intestinal stage adult immature adult fourth stage larvae hookworm species ancylostoma tubaeforme x x x roundworm species toxocara cati x x advantage multi for cats is indicated for the prevention of heartworm disease in ferrets caused by dirofilaria immiti s. advantage multi for cats kills adult fleas (ctenocephalides felis ) and is indicated for the treatment of flea infestations on ferrets.

Stati Uniti - Ingliż - NLM (National Library of Medicine)

elanco us inc. - lubabegron (unii: 8501207bzx) (lubabegron - unii:8501207bzx) - for reduction of ammonia gas emissions per pound of live weight and hot carcass weight in beef steers and heifers fed in confinement for slaughter during the last 14 to 91 days on feed. effectiveness has not been demonstrated when fed for less than 14 days. ammonia gas emissions were measured for individual animals or small groups of animals held in environmentally controlled facilities. based on existing information, reliable predictions of the reduction of ammonia gas emissions cannot be made on a herd, farm, or larger scale. increased rate of weight gain, improved feed efficiency, and increased carcass leanness have not been demonstrated with this product. the active ingredient in experior 10, lubabegron, is a beta-adrenergic agonist/antagonist. individuals with cardiovascular disease should exercise special caution to avoid exposure. not for human use. keep out of reach of children. when mixing and handling experior 10, use protective clothing, impervious gloves, protective eye wear, and a niosh-approved dust mask. operators should wash thoroughly with soap and water after handling. if accidental eye contact occurs, immediately rinse thoroughly with water; if wearing contact lenses, rinse eyes first, then remove contact lenses and continue to rinse for 5-20 minutes. if irritation persists, seek medical attention. the safety data sheet contains more detailed occupational safety information. to report adverse drug events, access medical information, or obtain additional product information, call elanco us inc. at 1-800-428-4441. for additional information about adverse drug experience reporting for animal drugs, contact fda at 1-888-fda-vets or http://www.fda.gov/reportanimalae lot no: expiry date:

Stati Uniti - Ingliż - NLM (National Library of Medicine)

elanco us inc. - lubabegron (unii: 8501207bzx) (lubabegron - unii:8501207bzx) - for reduction of ammonia gas emissions per pound of live weight and hot carcass weight in beef steers and heifers fed in confinement for slaughter during the last 14 to 91 days on feed. effectiveness has not been demonstrated when fed for less than 14 days. ammonia gas emissions were measured for individual animals or small groups of animals held in environmentally controlled facilities. based on existing information, reliable predictions of the reduction of ammonia gas emissions cannot be made on a herd, farm, or larger scale. increased rate of weight gain, improved feed efficiency, and increased carcass leanness have not been demonstrated with this product. the active ingredient in experior 50, lubabegron, is a beta-adrenergic agonist/antagonist. individuals with cardiovascular disease should exercise special caution to avoid exposure. not for human use. keep out of reach of children. when mixing and handling experior 50, use protective clothing, impervious gloves, protective eye wear, and a niosh-approved dust mask. operators should wash thoroughly with soap and water after handling. if accidental eye contact occurs, immediately rinse thoroughly with water; if wearing contact lenses, rinse eyes first, then remove contact lenses and continue to rinse for 5-20 minutes. if irritation persists, seek medical attention. the safety data sheet contains more detailed occupational safety information. to report adverse drug events, access medical information, or obtain additional product information, call elanco us inc. at 1-800-428-4441. for additional information about adverse drug experience reporting for animal drugs, contact fda at 1-888-fda-vets or http://www.fda.gov/reportanimalae lot no: expiry date:

Awstralja - Ingliż - APVMA (Australian Pesticides and Veterinary Medicines Authority)

elanco australasia pty ltd - monensin as monensin sodium - misc. intra ruminal device - monensin as monensin sodium antiprotozoal active 32.0 g/cp - alimentary system - cattle | dairy cattle | beef | bos indicus | bos taurus | bovine | breeders | buffalo | bull | bullock | calf | calves | cow | d - bloat | improvement of milk production | ketosis | productivity improvements | acetonaemia | bloated | colic | elevated ketones | frothy bloat | gas colic | improving feed efficiency | increasing rate of weight gain | legume bloat | non-clinical ketosis | weight gain

Stati Uniti - Ingliż - NLM (National Library of Medicine)

elanco us inc. - imidacloprid (unii: 3bn7m937v8) (imidacloprid - unii:3bn7m937v8) - advantus kills adult fleas and is indicated for the treatment of flea infestations on dogs and puppies 10 weeks of age and older and weighing 4 pounds or greater.

Stati Uniti - Ingliż - NLM (National Library of Medicine)

elanco us inc. - itraconazole (unii: 304nug5gf4) (itraconazole - unii:304nug5gf4) - itraconazole 10 mg in 1 ml - do not administer to cats with hypersensitivity to itraconazole. not for use in humans. keep this and all medications out of reach of children. wash hands and exposed skin after use. in case of accidental contact with eyes, rinse thoroughly with water. in case of pain or irritation, seek medical advice. in case of accidental ingestion, rinse mouth with water and seek medical advice. special precautions for person administering the veterinary product to the animal: microsporum canis dermatophytosis is a zoonotic disease (a disease that can be transmitted from animals to humans); therefore consult a physician if a suspected lesion occurs on a human. wear protective gloves when handling the animal during treatment or when cleaning the syringe. wash hands and exposed skin after handing the animal. itrafungol has not been shown to be sporicidal; therefore in order to reduce zoonotic potential, environmental contamination, and to decrease course of the disease, topical and environmental treatment should also be u

Stati Uniti - Ingliż - NLM (National Library of Medicine)

elanco us inc. - spinosad (unii: xpa88eap6v) (spinosad - unii:xpa88eap6v) - comfortis kills fleas and is indicated for the prevention and treatment of flea infestations (ctenocephalides felis ), for one month, on cats and kittens 14 weeks of age and older and 4.1 pounds of body weight or greater. there are no known contraindications for the use of comfortis. comfortis kills fleas and is indicated for the prevention and treatment of flea infestations (ctenocephalides felis ) for one month, on dogs and puppies 14 weeks of age and older and 5.0 pounds of body weight or greater. there are no known contraindications for the use of comfortis.

Stati Uniti - Ingliż - NLM (National Library of Medicine)

elanco us inc. - grapiprant (unii: j9f5zph7nb) (grapiprant - unii:j9f5zph7nb) - galliprant should not be used in dogs that have a hypersensitivity to grapiprant.

Stati Uniti - Ingliż - NLM (National Library of Medicine)

elanco us inc. - cyclosporine (unii: 83hn0gtj6d) (cyclosporine - unii:83hn0gtj6d) - cyclosporine 10 mg - atopica is indicated for the control of atopic dermatitis in dogs weighing at least 4 lbs. (1.8 kg) body weight. atopica is contraindicated for use in dogs with a history of neoplasia. do not use in dogs with a hypersensitivity to cyclosporine.